Patents by Inventor Ming Hsieh

Ming Hsieh has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8884424
    Abstract: A multilayer substrate includes a first outer conductive patterned layer, a first insulating layer exposing a portion of the first outer conductive patterned layer to define a first set of pads, a second outer conductive patterned layer, and a second insulating layer exposing a portion of the second outer conductive patterned layer to define a second set of pads. The multilayer substrate further includes inner layers each with an inner conductive patterned layer, multiple inner conductive posts formed adjacent to the inner conductive patterned layer, and an inner dielectric layer, where the inner conductive patterned layer and the inner conductive posts are embedded in the inner dielectric layer, and a top surface of each of the inner conductive posts is exposed from the inner dielectric layer.
    Type: Grant
    Filed: September 23, 2013
    Date of Patent: November 11, 2014
    Assignee: Advanced Semiconductor Engineering, Inc.
    Inventors: Yuan-Chang Su, Shih-Fu Huang, Chia-Cheng Chen, Tzu-Hui Chen, Kuang-Hsiung Chen, Pao-Ming Hsieh, Ming Chiang Lee, Bernd Karl Appelt
  • Patent number: 8877194
    Abstract: TNF-? binding proteins, including chimeric, CDR-grafted, and humanized antibodies that bind TNF-? are provided. Binding proteins have high affinity for TNF-? and neutralize TNF-? activity. A binding protein can be a full-length antibody or a TNF-?-binding portion thereof. Methods of making and methods of using the binding proteins are also described. The TNF-? binding proteins are useful for detecting TNF-? and for inhibiting TNF-? activity, including in a human subject suffering from a disease or disorder in which TNF-? activity is detrimental.
    Type: Grant
    Filed: December 8, 2011
    Date of Patent: November 4, 2014
    Assignee: AbbVie Inc.
    Inventors: Chung-ming Hsieh, Carrie L. Goodreau, Sahana Bose, Achim Moeller, Tariq Ghayur
  • Patent number: 8868937
    Abstract: A method of remotely controlling power distribution units enables the power distribution units to automatically transmit messages to a server once connected to the server via a network. When a user logs into a server and requests to remotely control the associated power distribution units, the user only needs to enter the serial numbers or identification data thereof. The server then automatically searches for all power distribution units owned by the user, and provides a group management interface. The user can then group the power distribution units according to their locations or their properties in order to control the on and off thereof. Without knowing the IP addresses of the power distribution units, the user can readily control the power distribution units at different locations remotely.
    Type: Grant
    Filed: June 8, 2011
    Date of Patent: October 21, 2014
    Assignee: Cyber Power Systems Inc.
    Inventors: Hsien-Hsun Liu, Hung-Ming Hsieh, Hung-Chun Chien
  • Publication number: 20140307184
    Abstract: A touch panel includes a substrate and a crossed sensing unit. The crossed sensing unit is disposed on the substrate, and the crossed sensing unit includes a first electrode, a second electrode, and a connecting line. The first electrode includes two sub electrodes disposed separately from each other and aligned along a first direction. The second electrode is disposed between the two sub electrodes. The connecting line is electrically connecting the two sub electrodes, and the connecting line does not overlap the second electrode along a vertical projective direction perpendicular to the substrate.
    Type: Application
    Filed: April 10, 2014
    Publication date: October 16, 2014
    Applicant: WINTEK CORPORATION
    Inventors: Chi-Ming Hsieh, Yi-Chen Tsai, Kuo-Chuan Tseng
  • Patent number: 8853365
    Abstract: The present invention relates to engineered multivalent and multispecific binding proteins, methods of making, and specifically to their uses in the prevention, diagnosis, and/or treatment of disease.
    Type: Grant
    Filed: December 20, 2011
    Date of Patent: October 7, 2014
    Assignee: ABBVIE Inc.
    Inventors: Chengbin Wu, Dominic J. Ambrosi, Chung-ming Hsieh, Tariq Ghayur
  • Patent number: 8841417
    Abstract: Proteins that bind IL-1? and IL-1? are described along with their use in compositions and methods for treating, preventing, and diagnosing IL-1-related disorders and for detecting IL-1? and IL-1? in cells, tissues, samples, and compositions.
    Type: Grant
    Filed: May 13, 2011
    Date of Patent: September 23, 2014
    Assignee: ABBVIE Inc.
    Inventors: Chengbin Wu, Dominic J. Ambrosi, Chung-ming Hsieh, Tariq Ghayur
  • Publication number: 20140268892
    Abstract: A converter with adjustable output voltage is coupled to a first power source and a second power source. The converter comprises a transformer, a first conversion circuit, a second conversion circuit, a resonant circuit and a regulating circuit. The first conversion circuit has a plurality of first switch elements, each of the first switch elements is coupled to the transformer. The second conversion circuit has a plurality of second switch elements, and each of the second switch elements is coupled to the transformer. The resonant circuit comprises a first inductor, at least one first capacitor and a second inductor. The first inductor is coupled in series to the transformer, and the first capacitor is coupled in parallel to the second conversion circuit. The second inductor is coupled to the first capacitor. The regulating circuit is coupled between the second power source and the second conversion circuit.
    Type: Application
    Filed: March 14, 2013
    Publication date: September 18, 2014
    Applicant: VOLTRONIC POWER TECHNOLOGY CORP.
    Inventors: BANG-HUA ZHOU, JIAN-QUN WU, JUOR-MING HSIEH
  • Publication number: 20140278213
    Abstract: One embodiment relates to a method to achieve enhanced overlay control while maintaining manufacturing throughput for a fabrication process. Locations of a plurality of alignment structures on a wafer comprising a plurality of reticle fields are determined with a layout tool to define a layout-based wafer map. The topography of the wafer is then measured as a function of wafer position by a surface measuring tool. The layout-based wafer map is then projected onto the measured wafer topography to define a modeled wafer map. A subset of alignment structure locations are measured with an alignment tool in an in-line fabrication flow so as not to delay subsequent fabrication steps. Disagreement between the measured alignment structure locations and modeled alignment structure locations is then minimized mathematically to enhance overlay control while maintaining manufacturing throughput.
    Type: Application
    Filed: July 16, 2013
    Publication date: September 18, 2014
    Inventors: Han-Ming Hsieh, Li-Shiuan Chen, Chung-Hao Chang, Li-Kong Turn
  • Publication number: 20140262907
    Abstract: A multi-layered packaging box with easy tearing structure includes a material box having: a seat; one lateral side of the seat having a breakable portion; a receiving space formed at a lower portion of the seat for receiving an object; an upper cover for covering the seat; a sealing film adhering on an upper portion of the upper cover; the sealing film having at least one tearing line; the sealing film including an easy tearing portion which can be torn away from the sealing film easily; and one end of the easy tearing portion adhering on the breakable portion. In above mentioned structure, the cover can be not used.
    Type: Application
    Filed: March 13, 2013
    Publication date: September 18, 2014
    Inventor: CHEN-MING HSIEH
  • Patent number: 8835610
    Abstract: Proteins that bind IL-17 and/or IL-17F are described along with their use in compositions and methods for treating, preventing, and diagnosing IL-17 related diseases and for detecting IL-17 in cells, tissues, samples, and compositions.
    Type: Grant
    Filed: March 5, 2010
    Date of Patent: September 16, 2014
    Assignee: Abbvie Inc.
    Inventors: Chung-Ming Hsieh, Margaret Hugunin, Yuliya Kutskova, John E. Memmott, Jennifer M. Perez, Suju Zhong, Edit Tarcsa, Anca Clabbers
  • Publication number: 20140243228
    Abstract: System and methods are disclosed for identifying and isolating antibodies with specific affinity with an antigen of interest. Multiple DNA libraries encoding antibodies or their fragments are designed such that the encoded antibodies from different libraries are tagged differently. These libraries may be transformed into yeast cells. The variants of the antibodies are displayed on the surface of the yeast cells and flow cytometry may be used to sort the cells based on antigen affinity and the different tags on the antibodies. By allowing multiple libraries to be screened simultaneously, the disclosed methods help improve the efficiency of affinity.
    Type: Application
    Filed: December 27, 2013
    Publication date: August 28, 2014
    Applicant: AbbVie, Inc.
    Inventors: Lorenzo BENATUIL, Jennifer PEREZ, Chung-Ming HSIEH
  • Publication number: 20140235476
    Abstract: Provided are protein, nucleic acid, and cellular libraries of multivalent binding proteins (e.g., DVD-Fab or DVD-Ig molecules) and the use of these libraries for the screening of multivalent binding proteins using cell surface display technology (e.g., yeast display).
    Type: Application
    Filed: December 27, 2013
    Publication date: August 21, 2014
    Applicant: AbbVie, Inc.
    Inventors: Jijie GU, Maria Cristina HARRIS, Lorenzo BENATUIL, Chung-Ming HSIEH
  • Publication number: 20140227294
    Abstract: The present invention encompasses PRLR binding proteins. Specifically, the invention relates to antibodies that are chimeric, CDR grafted and humanized antibodies. Preferred antibodies have high affinity for hPRLR and neutralize hPRLR activity in vitro and in vivo. An antibody of the invention can be a full-length antibody or an antigen-binding portion thereof. Methods of making and methods of using the antibodies of the invention are also provided. The antibodies, or antibody portions, of the invention are useful for detecting hPRLR and for inhibiting hPRLR activity, e.g., in a human subject suffering from a disorder in which hPRLR activity is detrimental. Also included in the invention are anti-PRLR antibody drug conjugates (ADCs).
    Type: Application
    Filed: December 23, 2013
    Publication date: August 14, 2014
    Applicant: ABBVIE INC.
    Inventors: Mark Anderson, Jieyi Wang, Archana Thakur, Debra Chao, Chung-Ming Hsieh, Qian Zhang, Edward B. Reilly, Enrico L. DiGiammarino, Kenton L. Longenecker, Russell A. Judge, David A. Egan, Charles W. Hutchins
  • Publication number: 20140227291
    Abstract: The present invention relates to amyloid-beta (A?) binding proteins. Antibodies of the invention have high affinity to A?(20-42) globulomer or any A? form that comprises the globulomer epitope. Method of making and method of using the antibodies of the invention are also provided.
    Type: Application
    Filed: August 12, 2011
    Publication date: August 14, 2014
    Inventors: Stefan Barghorn, Heinz Hillen, Andreas Striebinger, Simone Giasi, Ulrich Ebert, Chung-Ming Hsieh
  • Publication number: 20140220020
    Abstract: Proteins that bind IL-1? and IL-1? are described along with their use in compositions and methods for treating, preventing, and diagnosing IL-1-related disorders and for detecting IL-1? and IL-1? in cells, tissues, samples, and compositions.
    Type: Application
    Filed: December 26, 2013
    Publication date: August 7, 2014
    Applicant: AbbVie, Inc.
    Inventors: Chengbin WU, Dominic J. AMBROSI, Chung-ming HSIEH, Tariq GHAYUR
  • Publication number: 20140221621
    Abstract: Provided are protein, nucleic acid, and cellular libraries of single chain multivalent binding proteins (e.g., scDVD and scDVDFab molecules) and methods of using these of these libraries for the screening of single chain multivalent binding proteins using cell surface display technology (e.g., yeast display).
    Type: Application
    Filed: December 27, 2013
    Publication date: August 7, 2014
    Applicant: AbbVie, Inc.
    Inventors: Lorenzo BENATUIL, Chung-Ming HSIEH
  • Publication number: 20140212379
    Abstract: Proteins that bind IL-1? and IL-1? are described along with their use in compositions and methods for treating, preventing, and diagnosing IL-1-related disorders and for detecting IL-1? and IL-1? in cells, tissues, samples, and compositions.
    Type: Application
    Filed: December 16, 2013
    Publication date: July 31, 2014
    Applicant: AbbVie, Inc.
    Inventors: Chengbin WU, Dominic J. AMBROSI, Chung-ming HSIEH, Tariq GHAYUR
  • Publication number: 20140212925
    Abstract: Proteins that bind IL-1? and IL-1? are described along with their use in compositions and methods for treating, preventing, and diagnosing IL-1-related disorders and for detecting IL-1? and IL-1? in cells, tissues, samples, and compositions.
    Type: Application
    Filed: December 17, 2013
    Publication date: July 31, 2014
    Applicant: AbbVie, Inc.
    Inventors: Chengbin WU, Dominic J. AMBROSI, Chung-ming HSIEH, Tariq GHAYUR
  • Publication number: 20140213770
    Abstract: The present invention relates to improved methods for antibody engineering, e.g., humanization. In particular, the disclosure provides a high-throughput antibody humanization process that can be automated by computer-implementation.
    Type: Application
    Filed: December 20, 2013
    Publication date: July 31, 2014
    Applicant: AbbVie, Inc.
    Inventors: Feng DONG, Jijie GU, Chung-Ming HSIEH
  • Publication number: 20140205562
    Abstract: Proteins that bind IL-1? and IL-1? are described along with their use in compositions and methods for treating, preventing, and diagnosing IL-1-related disorders and for detecting IL-1? and IL-1? in cells, tissues, samples, and compositions.
    Type: Application
    Filed: December 18, 2013
    Publication date: July 24, 2014
    Applicant: AbbVie, Inc.
    Inventors: Chengbin WU, Dominic J. Ambrosi, Chung-ming Hsieh, Tariq Ghayur